TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in vitamin B12 absorption during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Scarring severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Image Quality of the CT Scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary C-reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate postoperative right cardiac failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of residual PAH six months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vascular Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Left Ventricular Energetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke
Endpoint domain: Mortality/survival
Primary endpoint: Composite of cardiovascular death, resuscitated cardiac arrest, non-fatal myocardial infarction, non-fatal stroke, heart failure, arterial revascularizations
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with positive response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of vaccinees who have seroconverted to DEN4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: vegetable consumption (servings/day) for child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole grains consumption (ounce equivalents/day) for child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reported total cups of vegetables per day (for adult)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of imaging readouts with tissue inflammatory biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in light intensity physical activity time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in moderate-vigorous intensity physical activity time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve (AUC) of Human Metapneumovirus (hMPV) Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean change in ABC-I score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Biomarker Concentrations: Nicotine Equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Biomarker Concentrations: NNAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted area under the curve (adj-AUC) of glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: area under the concentration-time curve from Hour 0 to the last measurable concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Fluid Given (ml/kg/Day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Fluid Bolused
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Time-weighted Average Heart Rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Concentration-time Curve From 0 to 24 Hours (AUC0-24hr) of MK-8521
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre-dose Trough Concentration (C0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Experience at Least 1 Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With TEAEs Related to Clinically Significant Laboratory Evaluation Findings
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With TEAEs Related to Clinically Significant Vital Sign Findings
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the Curve (AUC) of FVII:C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Collapsibility score for the IVC diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collapsibility score for the IVC diameter >= 50% (presence/absence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolism induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Systolic Blood Pressure Before and After Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diastolic Blood Pressure Before and After Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum Renin Level Before and After Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: grade 2 acute radiation dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in wrist acceleration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in stimulus response curve (SRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in short interval intracortical inhibition (SICI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum Iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Appetite
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percent change in seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rates of exit-site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of catheter-related bloodstream infections
Endpoint domain: Adverse events/effects
Primary endpoint: Face, Legs, Activity, Cry and Consolability Score (FLACC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose, triglycerides and cholesterol serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants with Hospital Readmission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Objective Polysomnography Sleep Duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Objective Actigraphy Sleep Duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Feasibility of administering TDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence of Mucus in the Paranasal Sinuses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of expertise
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pharmacokinetic characteristics (AUClast and Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of acute cholangitis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Taste Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taste and smell questionnaire responses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intra-ocular pressure increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thromboembolic events requiring hospitalisation
Endpoint domain: Adverse events/effects
Primary endpoint: Physician Awareness and Communication Rates
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Infant growth ratio from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined Incidence of HPV-related Cervical Intraepithelial Neoplasia Grades 2 or 3, Adenocarcinoma In Situ, and Cervical Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent Reduction in 24-hour Urine Protein Excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of POST scores >3
Endpoint domain: Adverse events/effects
Primary endpoint: Intraoperative temperature changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite pain assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve From Time Zero to Extrapolated Infinite Time [AUC (0-inf)] of MPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of MPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Terminal Half-Life (t1/2) of MPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of screen-detected prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stage of screen-detected prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pathology of screen-detected prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PET/MRI findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of fibrin function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measurement of thrombocyte function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measurement of global hemostatic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measurement of fibrinolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Iron status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Gut microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Asthma Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vessel diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Cross-sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: 89Zr-DFO-VRC01 temporal uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeatability of the 13C-glucose breath test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Congestive Heart Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrent Myocardial Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diameter of coagulative necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Operating Room Turnover Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hyponatremia presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ACT Total Score Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in NAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in ballooning degeneration score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no worsening of fibrosis score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease-free survival at three years
Endpoint domain: Mortality/survival
Primary endpoint: Disease-free survival at five years
Endpoint domain: Mortality/survival
Primary endpoint: Achievement of optimal sedation practice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Serious Adverse Event (AE)/Adverse Drug Reaction (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Unexpected AE/ADR
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Expected ADR
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Non-serious ADR
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with AEs of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of equine anti-SARS-CoV-2 immunoglobulins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of equine anti-SARS-CoV-2 immunoglobulins
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal and/or fetal severe complication
Endpoint domain: Adverse events/effects
Primary endpoint: change in peak positive power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of endotoxin positive subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity and specificity of the OraQuick rapid test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient relevant burden/benefit due to anticoagulation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic accuracy of the cataract AI agent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-PASS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fibrotic biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reverse remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Answers to questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain level measured by Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Infected Subjects
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of All-Cause Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Hot Flashes
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from Baseline in the Number of Monthly Migraine Headache Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cervicovaginal Fetal Fibronectin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Two-Year Event-Free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of positive screening for dysphagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants successfully completing the 1-year intervention
Endpoint domain: Mortality/survival
Primary endpoint: Chronic functional constipation symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of supplementary computer tomography and magnetic resonance imaging of the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: The number of blood sugar measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change Score for Scale for Suicide Ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complete response rate after induction chemotherapy with decitabine
Endpoint domain: Mortality/survival
Primary endpoint: Change in latency of the first REM episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Increase in Peak Walking Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentrations (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Observed Maximum Concentrations (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of miRNAs in the blood and CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number and percentage of subjects with elevated LOXL2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination rate constant [k]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: haematologic malignancies
Endpoint domain: Adverse events/effects
Primary endpoint: Newborn outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adverse perinatal outcome
Endpoint domain: Adverse events/effects
Primary endpoint: dP/dt measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral tissue oxygenation signals variability and repeatability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Consumption of Fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Clinical Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient dissatisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety/Tolerability of Study Medication
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Kansas-City Cardiomyopathy Questionnaire-Total Symptom Score (KCCQ-TSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in the CGI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acute hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change of Lung Clearance Index (LCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean Change in the Parent-Young Mania Rating Scale (P-YMRS) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Symptoms severity of obsessive and compulsive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The severity of and the degree of functional impairment from the post-dural puncture headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete or partial success at relieving headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in HbA1c From Baseline to Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Fasting Plasma Glucose From Baseline to Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blastocyst formation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment response based on platelet count shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Efficacy of sensory anesthesia and analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Camberwell Assessment of Need (CAN)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: World Health Organization Quality of Life, Short Form (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Seconder caries
Endpoint domain: Adverse events/effects
Primary endpoint: Variation in energy intakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Wounds Achieving Complete Wound Closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Quality of life assessment using Fibromyalgia Impact Questionnaire (FIQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants experiencing Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: 9-Month Target Vessel Revascularization (TVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Patients Not Completing Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: ipsilateral breast tumor recurrence (IBTR) at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to vaginal delivery of the neonate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Percent Change in Postprandial Glucose Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change in Fasting Glucose Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complexity of species composition in infant intestinal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Metabolic activities of infant intestinal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Functional examination for diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound (US) examination for diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint Contact Stress Time Exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plantar Force (Total Foot)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes